Astragaloside I and cycloastragenol supppressed the expressions of CK19, CK7, α-SMA, COL1A1, IL-1β, and IL-6 in DDC-induced CLD mice. The gene discussed is KRT19; the disease is congenital secretory chloride diarrhea 1.